Research Papers & Articles



1.   Shyam Sundar, Jaya Chakravarty & Lalit P Meena (2019) Leishmaniasis: treatment, drug resistance and emerging therapies, Expert Opinion on Orphan Drugs, 7:1, 1- 10, DOI: 10.1080/21678707.2019.1552853
2.   A Singh, A Agarwal, J Chakravarty, S Kumari, M Rai, S Sundar. Predictive Markers of Failure of First Line Anti Retroviral Treatment in HIV Patients in India. Journal of AIDS & Clinical Research. 4:210, 2013.
3.   Sundar S. What is the purpose of launching the World Journal of Clinical Infectious Diseases ? World J Clin Infect Dis. 1(1): 3, 2011.
4.   Boelaert M, Bhattacharya S, Chappuis F, El Safi SH, Hailu A, Mondal D, Rijal S, Sundar S, Wasunna M, Peeling RW. Evalation of rapid diagnostic tests: visceral leishmaniasis. Nat Rev Microbiol. (Suppl): S30-S36, 2007.
5.   Prakash J, Sundar S, Kar B, Sharma N, Raja R, Usha. Spectrum Of Renal Disease In Visceral Leishmaniasis. The Internet J Trop Med. Volume 4 Number 1, 2007.
6.   Kumar P, Pai K, Pandey, HP, Sundar S. Study on pinocytosis by monocytes from visceral leishmaniasis patients. Curr Science. 83: 631-33, 2002.
7.   Sundar S. Visceral leishmaniasis – Need for better drug. Ann Natl Acad Med Sci. 38: 147- 149, 2002.
8.   Singh VP, Sundar S, Rai M, Srinivasan A, Kumar V. The incidence and prevalence of opportunistic infections in patients with HIV/AIDS in developing countries. J Int Med India. 4: 41-3, 2001.
9.   Sundar S. Resurgence of kala-azar in India: reasons and remedies. J Int Med Scs Acad 13: 40-48, 2000.
10.               Sundar S. Management of kala-azar in India: Current concepts. J Ind Acad Clin Med 4: 104-109, 2000.
11.               Sundar S, GS Singh, Singh VP, N Singla, K Kumar, VK Vinayak. Comparative evaluation of DAT, IFAT and micro-ELISA in the serodiagnosis of Indian kala-azar. J Parasit Dis. 20: 41-3, 1997.
12.               Sundar S. Treatment of visceral leishmaniasis - Current status. J Assoc Physicians Ind 45: 640-45, 1997.
13.               Singh VP, Sundar S, N Gera, S Gupta, AK Gupta. Clinicopathological profile and therapeutic apparaisals in Lymphoma in Eastern UP. J Assoc Physicians Ind. 45: 690-2, 1997.
14.               Singh N, Nagar S, Roy U, Sundar S, Agrawal S, Rastogi AK. Antigenic analysis of soluble fraction of L. donovani by SDS-polyacrylamide gel electrophoresis and immunolblotting. Ind J Exp Biology. 33:313-315, 1995.
15.               NR Agrawal, AM Tripathi, TM Mahapatra, Sundar S. Effect of subclinical Malaria on fetal Development. J Obst Gyne India. 356-60,1994 .
16.               Sinha PR, Sundar S, Gupta PR. Two dimensional echocardiographic detection of biventricular thrombi in a case of idiopathic dilated cardiomyopathy. Amer J Non-invasive Cardiol. 7: 306-307, 1993.
17.               Kumar P, Singh VP, Sundar S and Dey AK. Assessment of physical efficiency level in anaemia. Ind J Haematology. 7: 109-12, 1989.
18.               Singh DS, Seecatt JS, Sundar S, Dube RK, Singh VP and Gupta JP. Platelet and Fibrinolytic activity in chronic active liver disease. Ind. J Haematology. 6: 135-8, 1988.
19.               Gambhir IS, Dube R, Singh VP, Singh DS and Sundar S. Paroxysmal Haemoglobinuria. Ind.J Haematology. 5: 165, 1987.
20.               Agrawal NR, Singh TJ, Sundar S, Bhattacharya SK, Pal D and Tiwari P. Utility of serum gentamycin levels in therapy of UTI. J Obst. Gynaecol India.35: 951, 1985.
21.               Shyam B, Gulati AK, Sundar Sand Somani PN. Complement fixing antibodies against coxsackie B viruses in clinical carditis. Ind. J. Med. Microbial.III: 171-5, 1985.